30. other financial liaBilities 31. other liaBilities Financial Section Annual Report 2014 _  Astellas Pharma Inc.  139 The breakdown of other liabilities is as follows: The maturity and the present value of finance lease liabilities are as follows: The breakdown of other financial liabilities is as follows: (Millions of yen) 1 April 2012  (Transition date) 2013 2014 Other financial liabilities (non-current) Financial liabilities measured at amortised cost Finance lease liabilities ¥ 800 ¥ 737 ¥ 749 Other 708 654 — Total other financial liabilities (non-current) 1,509 1,391 749 Other financial liabilities (current) Financial liabilities measured at amortised cost Finance lease liabilities 424 411 397 Other 721 959 664 Total other financial liabilities (current) 1,144 1,369 1,062 Total other financial liabilities ¥2,653 ¥2,761 ¥1,811 (Millions of yen) 1 April 2012  (Transition date) 2013 2014 Minimum lease payments Not later than one year ¥ 424 ¥ 411 ¥ 397 Later than one year and not later than five years 794 726 744 Later than five years 6 11 5 Present value of finance lease liabilities ¥1,224 ¥1,148 ¥1,146 (Millions of yen) 1 April 2012  (Transition date) 2013 2014 Other non-current liabilities Other long-term employee benefits ¥ 5,241 ¥ 8,245 ¥10,071 Other 1,490 1,898 1,610 Total other non-current liabilities ¥ 6,731 ¥10,142 ¥11,681 Other current liabilities Accrued bonuses ¥21,314 ¥25,041 ¥28,484 Accrued paid absences 7,617 7,833 9,827 Other accrued expenses 32,965 28,376 32,486 Other 2,805 2,068 2,153 Total other current liabilities ¥64,701 ¥63,319 ¥72,950